Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
AMGN compared with RXRX: revenue, margins and what each company keeps, and the suppliers and customers both name
AMGN
Amgen Inc
Change
Mkt cap
Revenue
Revenue
RXRX
Recursion Pharmaceuticals, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
AMGN
Amgen Inc
vs
RXRX
Recursion Pharmaceuticals, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
AMGN, solid
RXRX, dashed
AMGN
Amgen Inc
Change
466.31
· pre 465.85
Mkt cap
$251.9B
Revenue
$10.1B
Q2 FY26
Revenue
$36.8B
FY25
RXRX
Recursion Pharmaceuticals, Inc.
Change
4.03
· pre 4.05
Pre-market
Sep 2 '83
Mkt cap
$2.2B
Revenue
$8M
Q2 FY26
Revenue
$75M
FY25
vs
Compare
Pre-market
Sep 2 '83
AMGN
Amgen Inc
vs
RXRX
Recursion Pharmaceuticals, Inc.
466.31
pre 465.85
Price
4.03
pre 4.05
$251.9B
Mkt cap
$2.2B
Q2 FY26
$10.1B
Revenue
$8M
Q2 FY26
FY25
$36.8B
Revenue
$75M
FY25
Change
Change
AMGN
466.31
vs
RXRX
4.03
Pre-market
Sep 2 '83